Cargando…
Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study
The risk of SARS-CoV-2 reinfections changes as new variants emerge, but the follow-up time for most of the available evidence is shorter than two years. This study evaluated SARS-CoV-2 reinfection rates in the total population of an Italian province up to three years since the pandemic’s start. This...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672528/ https://www.ncbi.nlm.nih.gov/pubmed/38004251 http://dx.doi.org/10.3390/life13112111 |
_version_ | 1785140412269199360 |
---|---|
author | Acuti Martellucci, Cecilia Flacco, Maria Elena Soldato, Graziella Di Martino, Giuseppe Carota, Roberto Rosso, Annalisa De Benedictis, Marco Di Marco, Graziano Di Luzio, Rossano Lisbona, Francesco Caponetti, Antonio Manzoli, Lamberto |
author_facet | Acuti Martellucci, Cecilia Flacco, Maria Elena Soldato, Graziella Di Martino, Giuseppe Carota, Roberto Rosso, Annalisa De Benedictis, Marco Di Marco, Graziano Di Luzio, Rossano Lisbona, Francesco Caponetti, Antonio Manzoli, Lamberto |
author_sort | Acuti Martellucci, Cecilia |
collection | PubMed |
description | The risk of SARS-CoV-2 reinfections changes as new variants emerge, but the follow-up time for most of the available evidence is shorter than two years. This study evaluated SARS-CoV-2 reinfection rates in the total population of an Italian province up to three years since the pandemic’s start. This retrospective cohort study used official National Healthcare System data on SARS-CoV-2 testing and vaccinations, demographics, and hospitalizations in the Province of Pescara, Italy, from 2 March 2020 to 31 December 2022. A total of 6541 (5.4%) reinfections and 33 severe and 18 lethal COVID-19 cases were recorded among the 121,412 subjects who recovered from a primary infection. There were no severe events following reinfection in the young population, whereas 1.1% of reinfected elderly died. A significantly higher reinfection risk was observed among females; unvaccinated individuals; adults (30–59 y); and subjects with hypertension, COPD, and kidney disease. Up to three years after a primary SARS-CoV-2 infection, the majority of the population did not experience a reinfection. The risk of severe COVID-19 following a reinfection was very low for young and adult individuals but still high for the elderly. The subjects with hybrid immunity showed a lower reinfection risk than the unvaccinated. |
format | Online Article Text |
id | pubmed-10672528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106725282023-10-24 Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study Acuti Martellucci, Cecilia Flacco, Maria Elena Soldato, Graziella Di Martino, Giuseppe Carota, Roberto Rosso, Annalisa De Benedictis, Marco Di Marco, Graziano Di Luzio, Rossano Lisbona, Francesco Caponetti, Antonio Manzoli, Lamberto Life (Basel) Communication The risk of SARS-CoV-2 reinfections changes as new variants emerge, but the follow-up time for most of the available evidence is shorter than two years. This study evaluated SARS-CoV-2 reinfection rates in the total population of an Italian province up to three years since the pandemic’s start. This retrospective cohort study used official National Healthcare System data on SARS-CoV-2 testing and vaccinations, demographics, and hospitalizations in the Province of Pescara, Italy, from 2 March 2020 to 31 December 2022. A total of 6541 (5.4%) reinfections and 33 severe and 18 lethal COVID-19 cases were recorded among the 121,412 subjects who recovered from a primary infection. There were no severe events following reinfection in the young population, whereas 1.1% of reinfected elderly died. A significantly higher reinfection risk was observed among females; unvaccinated individuals; adults (30–59 y); and subjects with hypertension, COPD, and kidney disease. Up to three years after a primary SARS-CoV-2 infection, the majority of the population did not experience a reinfection. The risk of severe COVID-19 following a reinfection was very low for young and adult individuals but still high for the elderly. The subjects with hybrid immunity showed a lower reinfection risk than the unvaccinated. MDPI 2023-10-24 /pmc/articles/PMC10672528/ /pubmed/38004251 http://dx.doi.org/10.3390/life13112111 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Acuti Martellucci, Cecilia Flacco, Maria Elena Soldato, Graziella Di Martino, Giuseppe Carota, Roberto Rosso, Annalisa De Benedictis, Marco Di Marco, Graziano Di Luzio, Rossano Lisbona, Francesco Caponetti, Antonio Manzoli, Lamberto Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study |
title | Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study |
title_full | Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study |
title_fullStr | Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study |
title_full_unstemmed | Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study |
title_short | Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study |
title_sort | risk of sars-cov-2 reinfection 3 years after the start of the pandemic: a population-level observational study |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672528/ https://www.ncbi.nlm.nih.gov/pubmed/38004251 http://dx.doi.org/10.3390/life13112111 |
work_keys_str_mv | AT acutimartelluccicecilia riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT flaccomariaelena riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT soldatograziella riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT dimartinogiuseppe riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT carotaroberto riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT rossoannalisa riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT debenedictismarco riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT dimarcograziano riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT diluziorossano riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT lisbonafrancesco riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT caponettiantonio riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy AT manzolilamberto riskofsarscov2reinfection3yearsafterthestartofthepandemicapopulationlevelobservationalstudy |